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Abstract: Introduction: Currently, using various combinations of sedative and analgesic agents has received attention for
induction of sedation and analgesia due to their synergy in controlling pain and anxiety. The present study was
designed with the aim of comparing dexmedetomidine-fentanyl combination with midazolam-fentanyl in this
regard. Methods: In this randomized clinical trial, patients diagnosed with distal radius fracture who had vis-
ited the emergency department (ED) were allocated to either the group receiving the combination of fentanyl-
midazolam or the one receiving dexmedetomidine-fentanyl for procedural sedation and analgesia (PSA) and
were compared regarding analgesic characteristics, time to recovery and side effects. Results: 80 patients with
the mean age of 42.08 ± 12.17 (18 - 60) years were randomly allocated to 2 groups of 40 (83.80% male). The
2 groups did not have a significant difference regarding baseline characteristics as well as pain severity. Mean
pain score at the time of procedure was 3.47 ± 1.37 in dexmedetomidine and 2.85 ± 1.05 in midazolam group
(p = 0.025). In addition, time to recovery in dexmedetomidine and midazolam groups was 6.60 ± 1.86 minutes
and 12.70 ± 1.70 minutes, respectively (p < 0.001). Out of the 9 patients who experienced treatment failure, 8
(88.90%) patients were in dexmedetomidine group and 1 (11.10%) was in midazolam group (p = 0.029). Abso-
lute risk increase rate of treatment failure in case of using dexmedetomidine instead of midazolam was 17.50%
(95%CI: 4.19 – 30.81) and number needed to harm was 6.00 (95% CI: 3.20 – 23.80). Conclusion: Although the
combination of dexmedetomidine-fentanyl had a shorter time to recovery compared to midazolam-fentanyl for
induction of sedation and analgesia, the treatment failure rate in case of using dexmedetomidine with 1 µg/kg
increased 17.5% and about 1 out of each 6 patients needed a rescue dose.
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1. Introduction
D
istal radius fracture is among the common orthope-
dic problems and preserving the function of the joint
by reduction, anatomic correction and fixating un-
der sedation and analgesia are the priorities of treating these
patients in emergency department (ED) (1). For reducing
pain at the time of reduction, various methods exist includ-
ing nerve block (2), hematoma block (3), and induction of se-
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dation and analgesia using various drug compounds avail-
able to the physicians handling these patients (4, 5).
Fewer side effects on the respiratory system and hemody-
namic status are among the characteristics desired by emer-
gency physicians when selecting a drug for use in induction
of sedation and analgesia. Currently, using various combi-
nations of sedative and analgesic agents has received atten-
tion in this regard due to their synergy in controlling pain
and anxiety. For this purpose, the combination of midazo-
lam and fentanyl, as a powerful and short acting synthetic
opiate and a fast acting benzodiazepine with a short half-
life, respectively, has been very desirable and frequently used
among emergency medicine specialists (6, 7). On the other
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hand, dexmedetomidine as a central alpha-2 agonist that
has received the official approval of American food and drug
administration (FDA) in 1999 and has sympatholytic, anti-
anxiety, pain relief, and analgesic effects has been considered
for induction of conscious sedation (8).
Findings of various studies on comparison of the sedative
effects of dexmedetomidine and midazolam is indicative of
their difference regarding time of recovery and side effects on
the respiratory system and hemodynamics (9, 10). Although
a study by Vazquez et al. indicated that the time to recovery
of midazolam was twice the time to recovery of dexmedeto-
midine (11), another study by Zeyneloglu et al. showed com-
pletely reversed results (12). It seems that dexmedetomidine
will have a more successful performance compared to mi-
dazolam in cases that sedation is required for airway pro-
cedures such as bronchoscopy (13). Therefore, the present
study was designed and performed with the aim of com-
paring dexmedetomidine and fentanyl combination with mi-
dazolam and fentanyl combination in induction of sedation
and analgesia for reduction of distal radius fracture in the ED.
2. Methods
2.1. Study design and setting
In the present single blind randomized clinical trial, patients
diagnosed with distal radius fracture who had visited the ED
of Imam Hossein and Hafte Tir Hospitals, Tehran, Iran, were
studied. The patients were allocated to either the group re-
ceiving the combination of fentanyl and midazolam (mida-
zolam group) or the one receiving dexmedetomidine and
fentanyl (dexmedetomidine group) for induction of sedation
and analgesia for reducing the fracture and the characteris-
tics of the 2 combinations were compared. This study was
approved by the ethics committee of faculty of medicine,
Shahid Beheshti University of Medical Sciences and was reg-
istered on the Iranian registry of clinical trials (IRCT) under
the number IRCT20160401027165N1. The researchers ad-
hered to ethical principles and confidentiality of patient data
throughout the study. Informed consent was obtained from
the patients for participating in the study.
2.2. Participants
All the patients with distal radius fractures who had pre-
sented in the working shifts of the senior resident in charge of
the study (including morning and night shifts in both week-
days and holidays) and aged between 18 and 60 years were
included in the study without any sex limitations and us-
ing non-probability consecutive sampling. Patients who had
a history of using antihypertensive or antihistamine medi-
cations, patients with head trauma and loss of conscious-
ness, severe chest trauma, cervical vertebra trauma with
unstable fracture, mental retardation, those who could not
verbally communicate, hemodynamically unstable patients,
those with a history of allergic reaction to drugs, addicts and
those who had a history of drug abuse, pregnant women,
and those with a history of cardiac disease (cardiac block and
bradycardia) were excluded from the study.
2.3. Intervention
After selecting the patients meeting the inclusion criteria,
the participants were randomly allocated to one of the study
groups. After establishment of proper peripheral vein, car-
diac monitoring, pulse oximetry, blood pressure monitoring
and preparing complete equipment for cardiopulmonary re-
suscitation on the patients’ bedside, attempts were made to
induce sedation and analgesia at the level of conscious seda-
tion. The patient and the person who was responsible for sta-
tistical analysis were blind to the type of drug used. A trained
nurse was in charge of preparing the 2 drug compounds used
in separate syringes looking the same. In addition, a se-
nior emergency medicine resident was in charge of the study
and data gathering under the supervision of an emergency
medicine specialist. We cannot be sure of the blinding of
the person gathering data to the type of treatment received,
due to the difference in the method of injecting midazolam
and dexmedetomidine and not performing double dummy
blinding. In this study, dose of dexmedetomidine (Huspiria
of USA, Behestan Phamaceutical CO, Iran) was considered
1µg/kg and was injected during 10 minutes in 100cc normal
saline. In addition, midazolam (Darupakhsh Co, Iran) with
dose of 0.01 mg/kg was administered via slow and titrated
intravenous injection. Fentanyl (Abu Ravihan Co, Iran) was
prescribed with 3 µg/kg body weight dose for both groups
and was administered via slow intravenous injection. Pain
severity of the patients was measured and recorded using vi-
sual analogue scale (VAS) once before administration of the
drugs and once before performing the procedure (10-15 min-
utes after drug administration). A score of 10 was considered
the worst pain score and 0 was the lowest score. At least 3
points decrease in pain severity 10-15 minutes after receiving
the drug was considered as treatment success and not de-
creasing as much was considered treatment failure. In case
the pain did not decrease in a maximum of 15 minutes af-
ter drug injection, another injection was done using fentanyl
with 3 µg/kg body weight dose but these patients were not
excluded from the final analysis.
2.4. Data gathering
To gather data, a designed checklist consisting of age, sex,
pain severity before intervention and 15 minutes after re-
ceiving the drug, duration of procedure, time to recovery,
and probable side effects (apnea, nausea and vomiting, hy-
potension, and bradycardia) was used. The person in charge
of data gathering was a senior emergency medicine resident
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Male 33 (85.0) 34 (82.5) 0.762
Female 7 (15.0) 6 (17.5)
Age (year)
18-45 16 (40.0) 9 (22.5)
45-55 5 (12.5) 11 (27.5) 0.120
55 ≤ 19 (47.5) 20 (50.0)
Table 2: Comparing mean pain severity at the time of reduction initiation (15 minutes after sedation), mean procedure duration and mean





Response to treatment 32 (80.0) 39 (97.5) 0.029
Treatment failure 8 (20.0) 1 (2.5)
Pain severity at the time of reduction 3.47 ± 1.37 2.85 ± 1.05 0.025
Procedure duration (minutes) 12.57 ± 1.75 12.60 ± 1.78 0.950
Time to recovery 6.60 ± 1.86 12.70 ± 1.70 < 0.001
Pain severity according to Visual analogue scale. Data were presented as mean ± standard deviation or number (%).
under the supervision of an emergency medicine specialist.
The duration of procedure was considered from the initia-
tion of reduction until the end of fixating the reduced bone.
In addition, time to recovery was considered the time inter-
val between the end of the procedure until complete regain
of consciousness and awakening of the patient
2.5. Statistical Analysis
For analyzing data, SPSS 21 statistical software was used. For
reporting data, frequency and percentage, or mean ± stan-
dard deviation were used. Minimum required sample size for
performing the study was determined as 40 patients in each
group considering type 1 error of 5%, 95% power, 96% and
67% probability of failure for the 2 groups (12) and the min-
imum clinically significant difference of 30%. To compare
the results between the 2 groups, statistical tests including t-
test, chi-square, and Fisher’s exact test were applied. In addi-
tion, the rate of absolute risk increase and number needed to
harm of treatment failure in case of using dexmedetomidine
instead of midazolam was calculated using a medical calcu-
lator and reported. Level of significance was considered to be
5%.
3. Results
3.1. Baseline characteristics of the patients
80 patients with the mean age of 42.08 ± 12.17 (18 - 60)
years were randomly allocated to 2 groups of 40 and studied
(83.80% male). Table 1 compares the age and sex distribution
of the patients in the 2 groups. Mean age in dexmedetomi-
dine group was 40.65 ± 13.25 and it was 43.52 ± 10.95 years
in midazolam group (p = 0.294). All the studied patients had
a pain severity equal to or greater than 6 in the beginning of
reduction. Mean pain severity in dexmedetomidine and mi-
dazolam groups before reduction was 8.28 ± 1.13 and 8.18 ±
1.08, respectively (p = 0.688).
3.2. Response to treatment
Overall, 71 (88.80%) patients experienced 3 points decrease
in pain score after receiving the drug. Out of the 9 patients
who experienced treatment failure, 8 (88.90%) patients were
in dexmedetomidine group and 1 (11.10%) was in the mida-
zolam group (p = 0.029). Table 2 compares mean pain sever-
ity at the time of reduction, mean duration of reduction and
mean time to recovery between the 2 groups. Mean pain
score at the time of reduction was not significantly different
between the 2 groups from a clinical point of view; however,
dexmedetomidine group had a significantly shorter time to
recovery (p < 0.001). None of the patients in either group
experienced any special side effects including apnea, nau-
sea and vomiting, or hypotension. Only 3 (7.5%) patients
in dexmedetomidine group experience a short episode of
bradycardia, which was resolved by slowing the infusion rate
from 10 minutes to 15-20 minutes without hemodynamic im-
pairment.
Absolute risk increase rate of treatment failure in case of
using dexmedetomidine instead of midazolam was 17.50%
(95%CI: 4.19 – 30.81) and number needed to harm was 6.00
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(95% CI: 3.20 – 23.80).
4. Discussion
Based on the results of the present study, although the com-
bination of dexmedetomidine and fentanyl had a shorter
time to recovery compared to midazolam and fentanyl for in-
duction of sedation and analgesia, the treatment failure rate
in case of using dexmedetomidine with 1 µg/kg increased
17.5% and about 1 out of each 6 patients needed a rescue
dose.
After approval of dexmedetomidine as a sedative drug, var-
ious studies have been done regarding the effectiveness of
this drug and comparing it to other sedative drugs. A com-
parison between this drug and propofol has indicated the
similar sedative effects of both drugs despite the lower effect
of dexmedetomidine on the respiratory system and hemody-
namics (14, 15).
Senoglu et al. in a clinical trial on 40 patients in need of seda-
tion for non-invasive ventilation, prescribed midazolam for
1 group and dexmedetomidine for the other. Their findings
indicated the equal sedative effects of both drugs; however,
the group that received dexmedetomidine needed less dose
adjustment in comparison to midazolam (16). Dexmedeto-
midine has been successfully used in providing a conscious
sedation state without any respiratory distress and hemody-
namic instability throughout fiberoptic bronchoscopy (17).
Zeyneloglu et al. compared dexmedetomidine with mida-
zolam/fentanyl combination in inducing sedation for extra-
corporeal shock wave lithotripsy (ESWL) and showed that
the group receiving dexmedetomidine needed more rescue
doses and also more time to recovery (12). However, the find-
ings of the present study were in line with the mentioned one
regarding more need for rescue doses; however, they do not
agree regarding time to recovery.
In addition, Vazquez et al. compared midazolam and
dexmedetomidine for induction of sedation for endoscopy
of the upper digestive system and indicated that the group
that received dexmedetomidine had a significantly shorter
time to recovery and higher satisfaction. In this study, no
difference was reported between the 2 drugs regarding side
effects and sedative properties (11). The findings of this
study was in agreement with the results of the present study,
yet as reported in the results section, the patients receiv-
ing dexmedetomidine had a significantly higher rate of treat-
ment failure and more need for a rescue dose.
Regarding the side effects of these drugs on respiratory sys-
tem and hemodynamics there isn’t much of an agreement
between the studies. Although the findings of the study by
Frolich et al. indicate the superiority of midazolam for hav-
ing less effect on the mentioned systems (10), Shukry et al.
believe that when less effect on the airway and need for faster
awakening are priorities for the in-charge physician and the
patient, dexmedetomidine seems to be a proper choice (9).
The reason for these differences could be the different eth-
nic characteristics of the studied patients, different areas in
which the drugs were used, different doses of drugs, different
drug compounds and. . . . However, there is not much experi-
ence regarding use of dexmedetomidine specially in ED and
for induction of sedation and analgesia and to reach a final
decision on points such as time to recovery, side effects of
the drug on hemodynamics and respiratory system as well as
success and failure rates, further studies are required. Per-
forming multi-center studies with a big sample size and con-
sidering all the principles of clinical trials might help in this
regard.
5. Limitation
Not using double dummy blinding and the probability of the
person gathering data being aware of the drugs used can be
mentioned as the most important limitations of this study.
Additionally, not following patients regarding probable di-
gestive and other side effects during the hours after sedation
are among other limitations of the present study.
6. Conclusion
Based on the results of the present study, although the com-
bination of dexmedetomidine and fentanyl had a shorter
time to recovery compared to midazolam and fentanyl for in-
duction of sedation and analgesia, the treatment failure rate
in case of using dexmedetomidine with 1 µg/kg increased
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